SECsense Logo

Marker Therapeutics, Inc. 8-K Financial Report Insights - February 12, 2025

$MRKR
Form 8-K
Filed on: 2025-02-19
Source
Marker Therapeutics, Inc. 8-K Financial Report Insights - February 12, 2025

Here are the key insights extracted from the provided financial report section:

  1. Company Information:
  • Name: Marker Therapeutics, Inc.
  • CIK: 0001094038
  • Location: 2450 Holcombe Blvd, Suite BCM-A, MS: BCM251, Houston, TX 77021
  • Contact Number: 713-400-6400
  • Stock Symbol: MRKR
  • Exchange: NASDAQ
  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: February 12, 2025
  1. Financial Metrics:
  • Common Stock Par Value: $0.001 per share
  • Reporting Currency: USD
  1. Contextual Details:
  • Period Covered: The report covers a single day, February 12, 2025.
  • Identifier Scheme: The identifier scheme used is the SEC's CIK format.
  1. Units and Measures:
  • The financial report involves measurements in USD and shares, with a specific structure indicating a denominator of shares.

This information provides a snapshot of Marker Therapeutics, Inc.'s filing with the SEC, highlighting corporate details, the nature of the report, and relevant financial metrics.